Abstract
Rationale: Current invasive treatment for brain arteriovenous malformations (AVMs) is varied and includes endovascular procedures, neurosurgery, and radiotherapy alone and in combination, largely dependent on the decisions of the local clinical team. However, no controlled treatment data on invasive AVM therapy exist and recent data raise serious doubt about the treatment benefit for unruptured brain AVMs. We propose a randomized treatment trial testing the hypothesis that medical management improves long-term outcomes of patients with unruptured AVMs compared to invasive treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
